Program | Speaker |
|---|---|
Welcome and Introduction | Chair: Krista Kuitwaard (Rotterdam, Netherlands) |
Unravelling the Complexity of CIDP Diagnosis and Treatment | Krista Kuitwaard (Rotterdam, Netherlands) |
How Does IVIG Work in Autoimmune and Neuromuscular Diseases? | Aisling Carr (London, UK) |
Immunomodulation across Clinical Scenarios: Insights into Dermatomyositis | Carlo Selmi (Milan, Italy) |
Q&A | All Faculty |
Closing Remarks | Krista Kuitwaard (Rotterdam, Netherlands) |
Switzerland28/06/2026
A Spotlight on Rare Autoimmune Diseases
Octapharma Symposium at EAN 2026
)
Introduction
This symposium is taking place at the 12th Congress of the European Academy of Neurology (EAN) in Geneva, Switzerland, from June 27 to 30, 2026.
During this session, a panel of experts will explore the impact of immunomodulation in the management of chronic inflammatory demyelinating polyneuropathy (CIDP) and dermatomyositis (DM). The faculty will review current evidence on immune-mediated disease mechanisms and the role of intravenous immunoglobulin (IVIG) across neurological and rheumatological conditions, with particular emphasis on its clinical relevance in CIDP and DM.
Symposium Program
Sunday, June 28, 2026 | 12:45-13:45
Room Vienna
This scientific information may include data/information on investigational uses of compounds/drugs that have not yet been approved by regulatory authorities. This program was developed for use outside the U.S., is intended for non-U.S. HCPs, and is to be used in accordance with local laws and regulations.
Meet the speakers
Chair: Krista Kuitwaard
Erasmus University Medical Center, Rotterdam, Netherlands
Aisling Carr
National Hospital for Neurology and Neurosurgery
Carlo Selmi
Humanitas University, Milan, Italy